InfinityPro LLLT Red Light Therapy device for MGD treatment
InfinityPro

InfinityPro LLLT — Photobiomodulation Therapy

Low-Level Light Therapy (LLLT) — also known as Red Light Therapy or photobiomodulation — for meibomian gland dysfunction, periorbital skin applications, and the expanding category of LED-based eye-care therapies.

If your practice wants to add MGD treatment revenue without the complexity of a full procedural buildout, the InfinityPro is the lowest-barrier entry point available. Its LLLT (Red Light Therapy) design delivers photobiomodulation through six LED wavelengths spanning blue, green, yellow, pink, red, and near-infrared — the broadest spectrum on any single in-office LLLT device. The same red and near-infrared wavelengths InfinityPro uses for MGD therapy are the wavelengths now driving an expanding body of clinical research in retinal photobiomodulation, periorbital wound healing, and other LED-based eye-care applications. Treatments take 10–15 minutes, require zero consumables, minimal staff involvement, and patients find the experience genuinely comfortable. Use it as a standalone MGD treatment, as an adjunctive therapy alongside IPL/RF, or as a versatile in-office LED platform that grows with the science.

Request Pricing → Schedule a Demo →
Practice Fit

Where The InfinityPro Wins

InfinityPro is the easier entry point for practices that want a simple, non-invasive, technician-friendly MGD treatment offering.

Best Fit

Comprehensive optometry, MGD programs, and growth-minded practices that want a gentle treatment option that is easy to introduce without major workflow disruption.

Why This

If you want to add a low-barrier, high-compliance MGD treatment that patients enjoy receiving, InfinityPro’s LLLT (Red Light Therapy) design offers the broadest LED spectrum (5 colors plus infrared) with zero consumables and minimal staff time. It pairs well alongside IPL/RF treatments or works as a standalone therapy for practices not ready to start with more intensive procedures.

Practice Impact

It supports recurring treatment series, gives the practice a more approachable first step into MGD therapy, and can add revenue without the operational complexity of a larger procedural buildout.

Entry-Point Treatment

Why Practices Choose InfinityPro

Hands-Free Treatment

Hands-free design with 3 foldable LED panels requires no operator involvement during the 10–15 minute session. Position the panels, press start, and move on to your next task.

Low Staff Burden

No consumables, no per-click fees, no special training. Any staff member can run treatments from day one, and recurring sessions drive predictable revenue without adding operational complexity.

Adjunctive Flexibility

Use InfinityPro as a standalone therapy for mild-to-moderate MGD, as an entry point for practices testing the MGD treatment market, or as a complement to iProElite IPL/RF treatments for enhanced outcomes.

Expanding Applications

Beyond MGD — The Growing Science of Photobiomodulation

Low-Level Light Therapy (LLLT), also called photobiomodulation (PBM) or Red Light Therapy, applies specific wavelengths of red and near-infrared light to stimulate mitochondrial activity at the cellular level. The biophysical principles that make LLLT effective for meibomian gland dysfunction are the same principles now being applied across a widening range of in-office, periorbital, and research applications in eye care.

Meibomian Gland Dysfunction

The InfinityPro’s primary in-office application: photobiomodulation therapy for MGD — supporting meibomian gland function, reducing periorbital inflammation, and improving the quality of the lipid tear layer through repeated 10–15 minute sessions. Pairs effectively with IPL/RF protocols and diagnostic meibography workflows.

Retinal Photobiomodulation Research

The same red and near-infrared wavelengths the InfinityPro uses are central to a rapidly growing body of retinal photobiomodulation research. In November 2024 the FDA authorized the LumiThera Valeda Light Delivery System — the first multiwavelength PBM device cleared for vision loss in dry age-related macular degeneration (AMD) — establishing photobiomodulation as a recognized therapeutic category in retinal care.

Periorbital & Skin Health

InfinityPro’s six wavelengths (415 / 522 / 590 / 622 / 630 / 830 nm) are also well-suited to a range of periorbital and skin applications — from rejuvenation and pigmentation to inflammation reduction and wound-healing support — without consumables, click fees, or downtime.

The Mechanism: Why LLLT Works

Photobiomodulation works at the mitochondrial level. Cytochrome c oxidase — a primary photoreceptor in the red and near-infrared spectrum — absorbs LLLT photons, accelerating electron transport, increasing ATP production, and reducing oxidative stress. Because retinal photoreceptors are among the most metabolically demanding cells in the body, ocular tissues respond particularly well to this kind of light energy.

This is the same mitochondrial pathway underlying both InfinityPro’s established MGD application and the broader retinal-PBM research now reaching clinical practice.

Areas of Active Research

  • • Meibomian gland dysfunction & lipid tear layer
  • • Dry age-related macular degeneration (AMD)
  • • Retinal neuroprotection & mitochondrial support
  • • Repeated low-level red-light for myopia control
  • • Periorbital wound-healing & inflammation
  • • Skin rejuvenation, acne, pigmentation, redness

Disclosure: InfinityPro is an LED low-level light therapy platform. The MGD application is its primary established in-office use in eye care. Retinal and other applications described above reflect the broader photobiomodulation research category and are not specific FDA-cleared indications for the InfinityPro device. Discuss treatment indications, protocols, and applicable manufacturer labeling before applying any device outside its cleared indications. Selected references: Multiwavelength PBM for AMD systematic review (Ophthalmology & Therapy, 2025); PBM Therapy Delays Dry AMD Progression (Retinal Physician, 2025); PBM Therapy for Management of Retinal Diseases (Current Ophthalmology Reports, 2025).

Specifications

Technical Details

Technology
LED-based low-level light therapy (photobiomodulation)
LED Wavelengths
Six wavelengths: blue 415 nm, green 522 nm, yellow 590 nm, pink (415+630 nm), red 622 nm, near-infrared 830 nm; any visible color combinable with IR
Panel Configuration
3 foldable LED panels; wraparound treatment head
Light Modes
Continuous and pulsating; any color combinable with IR
Treatment Time
10–15 minutes per session (12 min in combined protocol)
User Interface
10-inch touchscreen display
Safety
No UV exposure; safe for all skin types; no heat or discomfort
Warranty
2-year extended warranty; no consumables, no click fees
The Carolina Optics Advantage

Why buy through us?

MGD Program Launch Support

We help you design a complete MGD program — from diagnostic workup protocols to treatment pricing, patient communication, and staff training.

On-Site Installation & Training

Our team handles setup, calibration, and hands-on training so your staff is comfortable with every diagnostic mode and treatment protocol from day one.

Same-Day Support

When you need help, you get our team directly — no call center, no ticket queue. Most issues resolved within 24 hours.

Ready to see the InfinityPro in action?

Talk to our team about pricing, availability, and scheduling a hands-on demo at your practice.

Request Pricing → Schedule a Demo →